MOTS - Spark Newswire

2 minute read

Earnings

Motus GI Hldgs’s Return On Capital Employed Overview

Today, 6:23 AM

According to data from Benzinga Pro, during Q4, Motus GI Hldgs's (NASDAQ:MOTS) reported sales totaled $99.00 thousand. Despite a 0.12% increase in earnings, the company posted a loss of $4.82 million.

MOTS

5 minute read

Earnings Scheduled For March 29, 2022

By Benzinga Insights

Today, 6:23 AM

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

AMPE

3 minute read

36 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 6:23 AM

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday.

AMBA

2 minute read

27 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 6:23 AM

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 123.4% to $0.76 in pre-market trading after jumping 36% on Monday.

AREB

3 minute read

32 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 6:23 AM

Gainers

AGFY

3 minute read

FDA
News

Motus GI Receives FDA Clearance To Market The Pure-Vu EVS System

By Benzinga Newsdesk

Today, 6:23 AM

Motus GI Holdings, Inc., (NASDAQ:MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency

MOTS